Sue Hughes
News
CVST after COVID-19 vaccine: New data confirm high mortality rate
September 30, 2021
“This is the biggest series, and as an international series, it gives a broader perspective from a larger range of countries.”
![1]()
News
Statins again linked to lower COVID-19 mortality
July 21, 2021
Patients hospitalized for COVID-19 who had been taking statins had a substantially lower risk of death and severe outcomes than those who weren’t in a large observational study.
News
New details of myocarditis linked to COVID vaccines
July 2, 2021
Further details from multiple cases of myocarditis linked to the Pfizer and Moderna mRNA COVID vaccines have been described in recent papers in the medical literature.
News
Large vessel stroke linked to AstraZeneca COVID vaccine
May 26, 2021
Three cases occurred in two women and one man in their 30s or 40s and involved blockages of the carotid and middle cerebral artery.
News
Atorvastatin: A potential treatment in COVID-19?
May 19, 2021
Atorvastatin was not associated with any significant differences in any of the individual components of the primary composite endpoint.
News
Infective endocarditis with stroke after TAVR has ‘dismal’ prognosis
May 7, 2021
More than half die during the index hospitalization and two-thirds within the first year, a new study shows.
News
Stroke is ‘not a common complication’ in COVID-19
April 20, 2021
Among the sickest of COVID patients – those admitted to an ICU – researchers found that stroke was not a common complication.
News
Novel antiplatelet drug: Hope for efficacy without bleeding?
April 12, 2021
A new antiplatelet drug with a completely novel mechanism of action could hold the promise of delivering the holy grail – reducing cardiac events without increasing bleeding.
News
AstraZeneca COVID vaccine: Clotting disorder mechanism revealed?
April 2, 2021
The vaccine may be linked to a condition that clinically resembles heparin-induced thrombocytopenia and seems to occur mainly in younger women.
News
Late-window stroke thrombolysis not linked to clot migration
March 3, 2021
This is the first randomized controlled study to assess the effect of thrombolysis on clot migration and accessibility in an extended time window.
